RMTI
Rockwell Medical IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$35.07M
P/E Ratio
—
EPS
$-0.15
Beta
1.66
52W High
$2.10
52W Low
$0.78
50-Day MA
$0.92
200-Day MA
$1.06
Dividend Yield
—
Profit Margin
-7.67%
Forward P/E
33.00
PEG Ratio
4.43
About Rockwell Medical Inc
Rockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment and hemodialysis products and therapies in the United States and internationally. The company is headquartered in Wixom, Michigan.
Fundamentals
| Revenue (TTM) | $69.26M |
| Gross Profit (TTM) | $11.70M |
| EBITDA | $-2.50M |
| Operating Margin | -2.17% |
| Return on Equity | -15.30% |
| Return on Assets | -5.04% |
| Revenue/Share (TTM) | $1.93 |
| Book Value | $0.94 |
| Price-to-Book | 0.94 |
| Price-to-Sales (TTM) | 0.51 |
| EV/Revenue | 0.323 |
| EV/EBITDA | 22.09 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -25.60% |
| Shares Outstanding | $39.41M |
| Float | $35.20M |
| % Insiders | 12.60% |
| % Institutions | 9.31% |
Historical Volatility
HV 10-Day
54.41%
HV 20-Day
42.45%
HV 30-Day
55.70%
HV 60-Day
55.73%
HV Rank
14.3%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/5/2026